chr9-95480451-G-C
Variant summary
The NM_000264.5(PTCH1):c.884C>G (p.Pro295Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The gene PTCH1 is a tumor suppressor gene (CancerMine: 35 TSG, 20 oncogene, 13 driver citations). The gene PTCH1 is a known oncogene (CancerMine: 35 TSG, 20 oncogene, 13 driver citations). The gene PTCH1 is a cancer driver gene (CancerMine: 35 TSG, 20 oncogene, 13 driver citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 9.60). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.P295L: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 135908); p.P295= (synonymous): Likely_benign (ClinVar VariationId 1764907, 1 star); p.P295= (synonymous): Likely_benign (ClinVar VariationId 2916215, 2 stars); p.P295S: Uncertain_significance (ClinVar VariationId 2633768, 2 stars); p.P295T: Uncertain_significance (ClinVar VariationId 4862716, 1 star) The variant has been observed in cBioPortal in 1 sample across 1 study and 1 cancer type; somatic enrichment level: NONE (Observed in at most one deduplicated cBioPortal case.).
Frequency
Consequence
NM_000264.5 missense
Scores
Clinical Significance
Conservation
Publications
- basal cell nevus syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia
- holoprosencephaly 7Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
- nevoid basal cell carcinoma syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, ClinGen
- exstrophy-epispadias complexInheritance: AD Classification: STRONG Submitted by: PanelApp Australia
- holoprosencephalyInheritance: AD Classification: LIMITED Submitted by: Illumina, ClinGen
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 3 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2]) | ||
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000264.5. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
PTCH1 | MANE Select | c.884C>G p.Pro295Arg | missense | Exon 6 of 24 | Prot: NP_000255.2 UniProt: | |
PTCH1 | MANE Plus Clinical | c.881C>G p.Pro294Arg | missense | Exon 6 of 24 | Prot: NP_001077072.1 UniProt: | |
PTCH1 | c.884C>G p.Pro295Arg | missense | Exon 6 of 23 | Prot: NP_001341847.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
PTCH1 | TSL:5MANE Select | c.884C>G p.Pro295Arg | missense | Exon 6 of 24 | Prot: ENSP00000332353.6 UniProt: | |
PTCH1 | TSL:5MANE Plus Clinical | c.881C>G p.Pro294Arg | missense | Exon 6 of 24 | Prot: ENSP00000389744.2 UniProt: | |
PTCH1 | TSL:1 | c.431C>G p.Pro144Arg | missense | Exon 6 of 24 | Prot: ENSP00000414823.2 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:31 | ||||
GnomAD4 exome | Cov:31 | ||||
GnomAD4 genome | Cov:31 | ||||
ClinVar
Not reported inComputational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 25 | |
AlphaMissense | Uncertain | 0.54 | |
BayesDel_addAF | Pathogenic | 0.51 | D |
BayesDel_noAF | Pathogenic | 0.49 | |
CADD | Pathogenic | 28 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Pathogenic | 0.86 | D |
Eigen | Pathogenic | 1.0 | |
Eigen_PC | Pathogenic | 0.97 | |
FATHMM_MKL | Pathogenic | 1.0 | D |
FuncVEP CTI | Pathogenic | 0.59 | |
GPN-Star LLR | N/A | -8.7 | |
GPN-Star score | N/A | 8.7 | |
LIST_S2 | Uncertain | 0.96 | D |
M_CAP | Pathogenic | 0.41 | D |
MetaRNN | Pathogenic | 0.92 | D |
MetaSVM | Pathogenic | 0.97 | D |
Mutation Taster | N/A | 2/98 | disease causing |
MutationAssessor | Pathogenic | 3.0 | M |
PhyloP100 | Pathogenic | 9.6 | |
popEVE | Benign | -3.5 | |
PrimateAI | Pathogenic | 0.84 | D |
PromoterAI | N/A | -0.044 | Neutral |
PROVEAN | Pathogenic | -8.6 | D |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.7 | |
REVEL | Pathogenic | 0.91 | |
Sift | Uncertain | 0.0020 | D |
Sift4G | Pathogenic | 0.0 | D |
Varity_R | N/A | 0.86 | |
VESM-3B | Benign | -10 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.